MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹85 Cr | ₹83 Cr | ₹73 Cr | ₹53 Cr | ₹56 Cr |
What is the latest Total Current Liabilities ratio of MEDICAMEN BIOTECH ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹85 Cr |
Mar2023 | ₹83 Cr |
Mar2022 | ₹73 Cr |
Mar2021 | ₹53 Cr |
Mar2020 | ₹56 Cr |
How is Total Current Liabilities of MEDICAMEN BIOTECH Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹85 Cr | 2.40 | |
Mar2023 | ₹83 Cr | 13.60 | |
Mar2022 | ₹73 Cr | 36.45 | |
Mar2021 | ₹53 Cr | -5.68 | |
Mar2020 | ₹56 Cr | - |
Compare Total Current Liabilities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹592.5 Cr | -10.8% | -1.9% | -2.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -2.8% | -3.6% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.5% | 1.5% | 59.1% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | -1.5% | 0.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.6% | -9.2% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,002.4 Cr | -7.4% | -5.1% | 9.9% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | -10.8% |
-1.9% |
-2.8% |
SENSEX | -2.7% |
-0.4% |
6.4% |
You may also like the below Video Courses